Skip to main content


MAGIA2Market follows on from the first phase of the MAGIA project which ended on December 31, 2019. The second phase, MAGIA2MArket, once again brings together the four main European MedTech clusters: bioPmed (coordinator, Piedmont), BioWin (Wallonia), Life Science Nord (Northern Germany) and Lyonbiopole (Auvergne-Rhône-Alpes) who are joining forces to pursue...
Read More


MAGIA, The European MedTech Alliance dedicated to supporting the internationalization of SMEs, brings together 4 poles of excellence:  Lyonbiopôle (France), BioPmed (Italy), BioWin and Life Science Nord (Germany), and aims to achieve a solid and reciprocal understanding of the activities of the four clusters in order to strengthen their collaboration. In this context, each...
Read More


For the cluster, S3MartMed constitutes an opportunity to develop a partnership with 4 other European clusters of excellence - BioPmed (Italy), BioRegio STERN Management (Germany), Lyonbiopôle (France) and MedSilesia (Poland) - in order to identify in the medical technology sector: Future key investment priorities, Joint activities for the emergence of interregional collaborations (commercial...
Read More


The project CE4BIG – Cluster Excellence for Business Innovation and Growth in the Health Sector, was selected to receive funding under the EU COSME  “European Cluster Excellence” initiative. MAIN OBJECTIVE The project aims to foster cluster collaboration on a European-wide scale. The ultimate objective is to strengthen both, clusters and SMEs, to...
Read More


Development of new therapeutic approaches for the treatment of inflammatory mono-arthritis combining “novel” anti-TNF-α and viscoelastic scaffold Mono-arthritis is generally treated by intra-articular injections of corticosteroids or of hyaluronic acid. However, due to their limited efficacy, or due to their toxicity, injectable corticosteroids are only administered a few times, which...
Read More


Drug-releasing electrode with enhanced properties This project is about the development of an implantable electrode with quantitative drug eluting capacity. Polypyrrole coating of platinum nanostructuresformsthe basis of thisinnovative technology. Two lines of application are foreseen: one is to exploit the release of an anti-inflammatory drug in order to limit the...
Read More


Bacteria and Resistance to Antibiotics. Identification using Nanotechnology and Microfluidics The goal of this project is to develop an in vitro test to identify the pathogenic bacteria and resistance parameters to antibiotics commonly encountered in human bacteremia. Doctors need a quick test to define the rapidly the most adequate therapy....
Read More


Chitosan-based Targeting Drug Delivery Systems (Cs-tDDS) and their Proof of Concept Today, the most efficient therapeutic approaches in cancer rely on targeting the tumoral cells in order to enhance the therapeutic effect of the drug, to decrease its dosage and to limit its side effects. The TARGETUM Project aims at...
Read More


Development of new cell-based in vitro models for ADME/Toxicity screening, based on human adult progenitor/stem cells Characterization of a new drug candidate during preclinical evaluation includes, in addition to potency and safety an assessment of drug metabolism and pharmacokinetics. Drug metabolism studies require identification ofthe products of drug candidate metabolism,...
Read More

Secure your place for BioWin Day: empowering health, the premier event for professionals and decision-makers in the life sciences industry.

Register here!